Lamisil Uno

Terbinafine, the active ingredient in Lamisil Uno, is an allylamine antifungal presented as a topical cream for cutaneous use. It treats common fungal skin infections such as athlete's foot, ringworm and jock itch by targeting the fungal cell membrane. GNH USA supplies Lamisil Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Terbinafine is used to treat superficial fungal infections of the skin and hair. - Tinea pedis (athlete's foot): reduces itching, scaling and erythema caused by dermatophyte infection. - Tinea corporis (ringworm): clears annular lesions and prevents spread to adjacent skin. - Tinea cruris (jock itch): alleviates redness, maceration and discomfort in the groin area.

Terbinafine may cause local skin reactions and, rarely, systemic hypersensitivity.

Common Side Effects: - Burning sensation at the application site - Itching or pruritus - Redness or erythema - Dryness or peeling of skin - Mild rash - Stinging or tingling feeling

Serious or Rare Side Effects: - Severe allergic reaction (angioedema, anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Extensive skin blistering - Systemic hypersensitivity with fever - Significant swelling of face or throat

Before using Lamisil Uno, consider the following precautions. - Confirm diagnosis: ensure the condition is a dermatophyte infection before application. - Avoid broken skin: do not apply to open wounds or inflamed lesions. - Limited body surface: restrict use to affected areas and avoid extensive coverage. - Hepatic caution: use with care in patients with known liver disease, monitoring if systemic absorption is suspected. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Terbinafine topical has a low potential for systemic drug interactions, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use with other topical irritants (e.g., strong corticosteroids) may increase skin irritation. - Application over areas treated with chemical peels or laser therapy can exacerbate local reactions.

Moderate Interactions (Monitor Closely): - Use with other antifungal agents may alter therapeutic outcomes; monitor for reduced effectiveness. - Co‑application with moisturizers containing alcohol may increase dryness; observe skin condition. - Systemic terbinafine taken concurrently can increase overall exposure; assess for hepatic side effects.